Genea sells shareholding of Superior ART

12 February 2020 Position statement:

Genea Limited no longer holds a shareholding of Bangkok clinic, Superior ART. On 24 October 2019, Genea sold its 50 per cent shareholding to other joint venture partners for a sale price of THB1.1billion.

Genea, formally Sydney IVF established Superior ART in 2006 and has since seen the clinic grow to approximately 1,100 OPUs.

CEO of Genea Group, Tomas Stojanov and Scientific Director, Steven McArthur have been board members since 2012. As Directors, they have advised the clinic on corporate direction, introduced Genea’s world leading technology into their laboratories, shared Genea’s protocols and operating models and increased live birth rates dramatically for local patients.

Dr Stojanov said, “over the past 13 years we have grown Superior ART from a new clinic with no patients to one of Asia’s most successful operations. Genea are investigating opportunities to continue to provide fertility services to the region.”